Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qaelum is a private medical imaging software company and University Hospitals Leuven spin-off focused on patient safety, quality management, and workflow optimization in radiology and related imaging environments. The company develops commercial software products for radiation dose management, CT repeat analysis, contrast management, MRI efficiency, compliance management, forms, and exposure index monitoring. Its core product, DOSE, is a vendor-neutral radiation dose management solution used across multi-site, multi-modality imaging environments, and the company states that certain tools are certified as CE class IIb medical devices. Qaelum operates from Belgium with a U.S. subsidiary in New York and serves healthcare facilities internationally, with stated presence across Europe, the Middle East, Asia, and the United States. The business is best understood as a commercial healthcare software and medical device company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qaelum.